Item Details
Roche Reports CHF 46.49 Billion in Sales for the First Nine Months of 2026
On 22 October, Roche reported group sales of CHF 46.493 billion for January–September 2026, up 6% at constant exchange rates, with third-quarter sales increasing 7% at constant exchange rates. Growth was supported by medicines and diagnostics, including demand for key pharmaceutical products; healthcare providers and medical researchers can explore clinical-data analysis and research computing, while HPC can support suitable data-intensive workloads. Contact HPC for a project-specific quotation.
Get in Touch
We’ll get back to you shortly.